Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Boston Children's Hospital
Boston, Massachusetts
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 63
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Timothy Springer | Conflict of Interest | Morphic Therapeutics, Inc. | >$600,000 | 2019 |
| Yang Shi | Conflict of Interest | Constellation Pharmaceuticals, Inc. | >$600,000 | 2017 |
| John Brownstein | Conflict of Interest | Booz Allen Hamilton, Inc. and Epidemico, a wholly-owned subsidiary of Booz Allen Hamilton, Inc. | $300,000 - $349,999 | 2015 |
| Umut Ozcan | Conflict of Interest | ERX Pharmaceuticals, Inc. | $300,000 - $349,999 | 2018 |
| Donald Kohn | Conflict of Interest | Orchard Therapeutics | $150,000 - $199,999 | 2018 |
| Markus Frank | Conflict of Interest | Triceba Gmbh and Rheacell Gmbh & Co. KG | $150,000 - $199,999 | 2017 |
| Richard Malley | Conflict of Interest | Affinivax, Inc. | $100,000 - $149,999 | 2018 |
| Timothy Springer | Conflict of Interest | Morphic Therapeutic, Inc. | $80,000 - $99,999 | 2019 |
| Timothy Springer | Conflict of Interest | Morphic Therapeutics, Inc. | $80,000 - $99,999 | 2019 |
| Hao Wu | Conflict of Interest | SMOC Therapeutics | $80,000 - $99,999 | 2019 |
| Hao Wu | Conflict of Interest | SMOC Therapeutics | $80,000 - $99,999 | 2019 |
| Markus Frank | Conflict of Interest | Ticeba GmbH | $60,000 - $79,999 | 2016 |
| Markus Frank | Conflict of Interest | Ticeba GmbH | $40,000 - $59,999 | 2015 |
| Fan Zhang | Conflict of Interest | Affinivax, Inc. | $20,000 - $39,999 | 2018 |
| Yingjie Lu | Conflict of Interest | Affinivax, Inc. | $20,000 - $39,999 | 2018 |
| David Williams | Conflict of Interest | Orchard Therapeutics | $20,000 - $39,999 | 2018 |
| Leonard Bacharier | Conflict of Interest | Novartis | $10,000 - $19,999 | 2019 |
| Judy Lieberman | Conflict of Interest | SMOC Therapeutics | $10,000 - $19,999 | 2019 |
| Beth Stevens | Conflict of Interest | Annexon Biosciences | $10,000 - $19,999 | 2017 |
| Craig Gerard | Conflict of Interest | ChemoCentryx, CCXI | $5,000 - $9,999 | 2015 |
| Donald Kohn | Conflict of Interest | Orchard Therapeutics | $5,000 - $9,999 | 2018 |
| Robert Green | Conflict of Interest | Genome Medical | $5,000 - $9,999 | 2018 |
| Beth Stevens | Conflict of Interest | Annexon Biosciences | $0 - $4,999 | 2017 |
| Guergana Savova | Conflict of Interest | Wired Informatics, LLC | $0 - $4,999 | 2016 |
| Yang Shi | Conflict of Interest | Constellation Pharmaceuticals, Inc. | $0 - $4,999 | 2017 |
| Hao Wu | Conflict of Interest | SMOC Therapeutics | $0 - $4,999 | 2019 |
| Timothy Spring | Conflict of Interest | Morphic Rock Therapeutic, Inc. | $0 - $4,999 | 2016 |
| Tim Springer | Conflict of Interest | Morphic Rock Therapeutics, Inc. | $0 - $4,999 | 2017 |
| Natasha Frank | Conflict of Interest | Triceba Gmbh and Rheacell Gmbh & Co. KG | $0 - $4,999 | 2016 |
| Yi Zhang | Conflict of Interest | NewClone Biotechnology, Inc. | $0 - $4,999 | 2019 |
| Michael Costigan | Conflict of Interest | Quartet Medicine, Inc. | $0 - $4,999 | 2014 |
| Christopher Landrigan | Conflict of Interest | I-PASS Patient Safety Institute, Inc. | $0 - $4,999 | 2017 |
| Amy Starmer | Conflict of Interest | I-PASS Patient Safety Institute, Inc. | $0 - $4,999 | 2017 |
| George Daley | Conflict of Interest | 28-7 Therapeutics | $0 - $4,999 | 2016 |
| George Daley | Conflict of Interest | 28-7 Therapeutics | $0 - $4,999 | 2016 |
| David Mauger | Conflict of Interest | Novartis | $0 - $4,999 | 2018 |
| Craig Gerard | Conflict of Interest | ChemoCentryx, CCXI | $0 - $4,999 | 2015 |
| Hao Wu | Conflict of Interest | SMOC Therapeutics | $0 - $4,999 | 2019 |
| Alban Latremoliere | Conflict of Interest | Quartet Medicine, Inc. | $0 - $4,999 | 2014 |
| Timothy Springer | Conflict of Interest | Morphic Rock Therapeutic, Inc. | $0 - $4,999 | 2015 |
| Yingjie Lu | Conflict of Interest | Affinivax, Inc. | 2018 | |
| Tim Springer | Conflict of Interest | Morphic Rock Therapeutics, Inc. | 2017 | |
| Tim Springer | Conflict of Interest | Morphic Rock Therapeutics, Inc. | 2017 | |
| Maria Franceschini | Conflict of Interest | 149 Medical, Inc. | 2018 | |
| Georg Gerber | Conflict of Interest | Consortia Therapeutics | 2019 | |
| Judy Lieberman | Conflict of Interest | SMOC Therapeutics | 2019 | |
| Hao Wu | Conflict of Interest | SMOC Therapeutics | 2019 | |
| Hao Wu | Conflict of Interest | SMOC Therapeutics | 2019 | |
| Guergana Savova | Conflict of Interest | Wired Informatics, LLC | 2016 | |
| Robert Green | Conflict of Interest | Genome Medical | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.